CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates a novel treatment for inflammatory bowel diseases by inducing excess intestinal mucus secretion to protect against colitis. Using preclinical mouse models, it aims to establish a safe and effective method that could offer a non-immunosuppressive alternative for managing these chronic condition…
Inflammatory bowel diseases (IBDs), such as Crohns disease and ulcerative colitis, are chronic, debilitating conditions affecting millions worldwide.
There is currently no cure for IBD, only treatments aimed at inducing long lasting remission.
These treatment options act mainly by inhibiting the patients immune system, leaving patients immunocompromised, and come with a high annual direct cost.
Even with advanced treatment, most IBD patients will require surgery during their lifetimes.
Thus, mor…
BAR ILAN UNIVERSITY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
